Vigilare Wealth Management Purchases New Holdings in SPDR S&P Biotech ETF $XBI

Vigilare Wealth Management bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 6,430 shares of the exchange traded fund’s stock, valued at approximately $1,014,000.

Other institutional investors have also added to or reduced their stakes in the company. Ayalon Insurance Comp Ltd. grew its holdings in SPDR S&P Biotech ETF by 71.9% during the 3rd quarter. Ayalon Insurance Comp Ltd. now owns 95,600 shares of the exchange traded fund’s stock valued at $15,074,000 after buying an additional 40,000 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $19,270,000. TD Waterhouse Canada Inc. raised its stake in shares of SPDR S&P Biotech ETF by 535.1% in the second quarter. TD Waterhouse Canada Inc. now owns 5,265 shares of the exchange traded fund’s stock valued at $824,000 after acquiring an additional 4,436 shares during the period. Syon Capital LLC lifted its stake in SPDR S&P Biotech ETF by 67.9% in the second quarter. Syon Capital LLC now owns 23,562 shares of the exchange traded fund’s stock worth $3,729,000 after purchasing an additional 9,530 shares during the last quarter. Finally, Continuum Advisory LLC grew its stake in shares of SPDR S&P Biotech ETF by 389.1% during the second quarter. Continuum Advisory LLC now owns 18,013 shares of the exchange traded fund’s stock valued at $2,851,000 after buying an additional 14,330 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $155.98 on Monday. SPDR S&P Biotech ETF has a fifty-two week low of $106.30 and a fifty-two week high of $169.89. The company has a market cap of $10.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. The business’s 50 day moving average price is $156.60 and its 200-day moving average price is $141.58.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.